R STAHL (RSL2) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
10 Nov, 2026Executive summary
Q3 order intake rose 4.4% YoY to €75.4m, while sales fell 5.7% to €74.1m; sales improved sequentially from Q1 and Q2.
9M sales declined 4.4% to €219.7m; EBITDA pre increased to €21.7m from €20.2m, and net profit returned to €0.9m from a €2.4m loss.
Q3 net profit rose to €3.7m from €2.6m; operating cash flow was €14.2m and free cash flow €11.7m.
Order backlog declined 14.1% YoY to €90.9m at September 30.
Financial highlights
Q3 sales were €74.1m vs. €78.6m YoY; total operating performance was €76.2m vs. €86.3m.
Q3 EBITDA pre was €9.0m vs. €11.3m, EBITDA €8.7m vs. €8.9m, and EBIT €4.4m vs. €4.0m; the prior-year EBITDA pre reflected an unusually high result.
Q3 net profit was €3.7m vs. €2.6m and EPS €0.56 vs. €0.39; positive tax effects supported earnings.
9M EBITDA pre was €21.7m vs. €20.2m, EBITDA €19.9m vs. €16.3m, and EBIT €6.5m vs. €2.1m.
Q3 material ratio improved to 31.7% from 34.5%; personnel costs fell 11.8% to €30.5m, mainly due to workforce reductions.
Outlook and guidance
FY 2026 guidance confirmed: sales €285m–€300m, EBITDA pre €22m–€27m, balanced free cash flow and stable equity ratio, revised from a slight decrease.
Management expects order intake to convert into sales with a lag; positive intake trends and targeted market penetration support confidence in 2027 growth.
Guidance assumes comparable cost efficiency; investment plans may be adjusted to business development and uncertainty to protect financial stability.
The previously cited €500m 2030 revenue ambition was not reaffirmed; management emphasized stepwise organic progress.
Latest events from R STAHL
- Profitability improved on cost cuts, with Asia/Pacific strong and 2026 guidance confirmed.RSL2
Q2 2026 - Profitability improved on stable sales, with Asia-Pacific growth and ongoing transformation.RSL2
Q1 2026 - EBITDA margin stable at 11% despite sales drop; transformation targets €500M sales by 2030.RSL2
Q4 2025 - Sales fell 10.1% in Q3 2025, but EBITDA pre rose 28.8%; outlook for 2025 was revised downward.RSL2
Q3 2025 - Sharp declines in sales and profit led to negative outlook and cost-saving actions.RSL2
Q2 2025 - Sales up 1.7%, profit down 70.2%, 2024 EBITDA guidance narrowed to €35–40 million.RSL2
Q3 2024 - Strong sales and profit growth in Q2 2024, with positive outlook and improved equity ratio.RSL2
Q2 2024 - Record sales in 2024, but lower profitability and strong cash flow improvement amid uncertainty.RSL2
Q4 2024 - Record order intake but sales and profit declined; 2025 outlook and pipeline remain strong.RSL2
Q1 2025